PMCTPharmaCountry
    Home
Research & ReportsAug 25, 2026•1 min read

Study Links Paternal Valproate Use at Conception to Neurodevelopmental Risks in Children

By the PharmaCountry team

1

A study suggests valproate use by men near conception may be linked to higher risk of neurodevelopmental disorders in offspring.

A retrospective observational study has indicated a possible association between valproate use by men around the time of conception and an increased risk of neurodevelopmental disorders in their children. Inform male p…

Compiled by the PharmaCountry team · Source: MHRA

Topics:#valproate#paternal exposure#neurodevelopmental disorders#pharmacovigilance#reproductive safety

More articles

View all insights
Research & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory Updates
Korea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
Analysis
Pharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026